FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2018669222> ?p ?o ?g. }

• W2018669222 endingPage "2516" @default.
• W2018669222 startingPage "2507" @default.
• W2018669222 abstract "One hundred seventy-four evaluable patients with noninflammatory Stage III (both operable and inoperable) breast cancer were treated with a combined modality strategy between 1974 and 1985. All patients received combination chemotherapy with 5-fluorouracil, Adriamycin (doxorubicin), and cyclophosphamide (FAC) as their initial form of therapy. After three cycles of chemotherapy, local treatment in the form of a total mastectomy with axillary dissection, or radiotherapy, or both, was completed. Subsequently, adjuvant chemotherapy was continued. There were 48 patients with Stage IIIA, and 126 patients with Stage IIIB disease. A complete remission was achieved in 16.7% of the patients, and 70.7% achieved a partial remission after the initial three cycles of FAC. The complete response rate was higher for patients with Stage IIIA, than for patients with Stage IIIB disease. All but six of the 174 patients treated were rendered disease-free after induction chemotherapy and local treatment. The median follow-up of this group of patients is 59 months. The 5-year disease-free survival rates were 84% for patients with Stage IIIA, and 33% for patients with Stage IIIB disease. The 5-year survival rate for, patients with Stage IIIA was 84%, and for patients with Stage IIIB 44%. At 10 years, 56% of patients with Stage IIIA and 26% of patients with Stage IIIB disease are projected to be alive. Younger patients, and those with estrogen receptor-positive tumors, had a trend for better survival than older patients and those with estrogen receptor-negative tumors. The quality of response to induction chemotherapy correlated prominently with prognosis, as did compliance with treatment. Twenty-six patients (15.3%) had locoregional recurrence. This multidisciplinary approach to locally advanced breast cancer rendered most patients disease-free and produced an excellent local control rate. Modifications of this treatment strategy may result in further improvement of survival rates." @default.
• W2018669222 created "2016-06-24" @default.
• W2018669222 creator A5007108434 @default.
• W2018669222 creator A5015117682 @default.
• W2018669222 creator A5017898121 @default.
• W2018669222 creator A5018617106 @default.
• W2018669222 creator A5029049289 @default.
• W2018669222 creator A5030497065 @default.
• W2018669222 creator A5031531962 @default.
• W2018669222 creator A5055030811 @default.
• W2018669222 creator A5056620964 @default.
• W2018669222 creator A5060442480 @default.
• W2018669222 creator A5067012183 @default.
• W2018669222 creator A5071158497 @default.
• W2018669222 creator A5084775563 @default.
• W2018669222 date "1988-12-15" @default.
• W2018669222 modified "2023-09-27" @default.
• W2018669222 title "Management of stage III primary breast cancer with primary chemotherapy, surgery, and radiation therapy" @default.
• W2018669222 cites W1966158468 @default.
• W2018669222 cites W1972231056 @default.
• W2018669222 cites W1982230933 @default.
• W2018669222 cites W1987729795 @default.
• W2018669222 cites W1988920760 @default.
• W2018669222 cites W2005612511 @default.
• W2018669222 cites W2008686530 @default.
• W2018669222 cites W2033342482 @default.
• W2018669222 cites W2043663373 @default.
• W2018669222 cites W2048274084 @default.
• W2018669222 cites W2058681718 @default.
• W2018669222 cites W2060242711 @default.
• W2018669222 cites W2095259252 @default.
• W2018669222 cites W2114081348 @default.
• W2018669222 cites W2143594378 @default.
• W2018669222 cites W2157239524 @default.
• W2018669222 cites W2466505365 @default.
• W2018669222 cites W4239330499 @default.
• W2018669222 cites W4293241248 @default.
• W2018669222 doi "https://doi.org/10.1002/1097-0142(19881215)62:12<2507::aid-cncr2820621210>3.0.co;2-d" @default.
• W2018669222 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/3056604" @default.
• W2018669222 hasPublicationYear "1988" @default.
• W2018669222 type Work @default.
• W2018669222 sameAs 2018669222 @default.
• W2018669222 citedByCount "471" @default.
• W2018669222 countsByYear W20186692222012 @default.
• W2018669222 countsByYear W20186692222013 @default.
• W2018669222 countsByYear W20186692222014 @default.
• W2018669222 countsByYear W20186692222015 @default.
• W2018669222 countsByYear W20186692222016 @default.
• W2018669222 countsByYear W20186692222017 @default.
• W2018669222 countsByYear W20186692222018 @default.
• W2018669222 countsByYear W20186692222019 @default.
• W2018669222 countsByYear W20186692222020 @default.
• W2018669222 countsByYear W20186692222021 @default.
• W2018669222 countsByYear W20186692222022 @default.
• W2018669222 countsByYear W20186692222023 @default.
• W2018669222 crossrefType "journal-article" @default.
• W2018669222 hasAuthorship W2018669222A5007108434 @default.
• W2018669222 hasAuthorship W2018669222A5015117682 @default.
• W2018669222 hasAuthorship W2018669222A5017898121 @default.
• W2018669222 hasAuthorship W2018669222A5018617106 @default.
• W2018669222 hasAuthorship W2018669222A5029049289 @default.
• W2018669222 hasAuthorship W2018669222A5030497065 @default.
• W2018669222 hasAuthorship W2018669222A5031531962 @default.
• W2018669222 hasAuthorship W2018669222A5055030811 @default.
• W2018669222 hasAuthorship W2018669222A5056620964 @default.
• W2018669222 hasAuthorship W2018669222A5060442480 @default.
• W2018669222 hasAuthorship W2018669222A5067012183 @default.
• W2018669222 hasAuthorship W2018669222A5071158497 @default.
• W2018669222 hasAuthorship W2018669222A5084775563 @default.
• W2018669222 hasConcept C121608353 @default.
• W2018669222 hasConcept C126322002 @default.
• W2018669222 hasConcept C141071460 @default.
• W2018669222 hasConcept C143998085 @default.
• W2018669222 hasConcept C146357865 @default.
• W2018669222 hasConcept C151730666 @default.
• W2018669222 hasConcept C2776283816 @default.
• W2018669222 hasConcept C2776611710 @default.
• W2018669222 hasConcept C2776694085 @default.
• W2018669222 hasConcept C2776755627 @default.
• W2018669222 hasConcept C2777757722 @default.
• W2018669222 hasConcept C509974204 @default.
• W2018669222 hasConcept C530470458 @default.
• W2018669222 hasConcept C71924100 @default.
• W2018669222 hasConcept C86803240 @default.
• W2018669222 hasConceptScore W2018669222C121608353 @default.
• W2018669222 hasConceptScore W2018669222C126322002 @default.
• W2018669222 hasConceptScore W2018669222C141071460 @default.
• W2018669222 hasConceptScore W2018669222C143998085 @default.
• W2018669222 hasConceptScore W2018669222C146357865 @default.
• W2018669222 hasConceptScore W2018669222C151730666 @default.
• W2018669222 hasConceptScore W2018669222C2776283816 @default.
• W2018669222 hasConceptScore W2018669222C2776611710 @default.
• W2018669222 hasConceptScore W2018669222C2776694085 @default.
• W2018669222 hasConceptScore W2018669222C2776755627 @default.
• W2018669222 hasConceptScore W2018669222C2777757722 @default.
• W2018669222 hasConceptScore W2018669222C509974204 @default.
• W2018669222 hasConceptScore W2018669222C530470458 @default.
• W2018669222 hasConceptScore W2018669222C71924100 @default.

• next